Brooklyn Immunotherapeutics Inc
Change company Symbol lookup
Select an option...
BTX Brooklyn Immunotherapeutics Inc
SBCF Seacoast Banking Corporation of Florida
MSSAU Metal Sky Star Acquisition Corp
SDGR Schrodinger Inc
GPC Genuine Parts Co
VENA Venus Acquisition Corp
VECO Veeco Instruments Inc
IGTAU Inception Growth Acquisition Ltd
BAC-K Bank of America Corp
FAX abrdn Asia-Pacific Income Fund Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Brooklyn ImmunoTherapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cytokine-based therapies for treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its lead product candidate, IRX-2, is a cytokine therapy, to treat patients with head and neck cancer. IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2 (IL2) and other key cytokines, which restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. The Company also has multiple cell and gene-editing therapies in preclinical development for various indications, including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. Its subsidiaries include Brooklyn ImmunoTherapeutics LLC, Novellus, Inc. and Novellus Therapeutics, Ltd.

Closing Price
$0.2303
Day's Change
-0.0319 (-12.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2993
Day's Low
0.2303
Volume
(Heavy Day)
Volume:
1,727,500

10-day average volume:
815,612
1,727,500

Georgia Tech Financial Services Innovation Lab and Fiserv Partner to Advance Insight into Consumer Finances and Further Financial Inclusion

9:00 am ET July 22, 2022 (BusinessWire) Print

The Financial Services Innovation Lab (FSIL), which serves as an interface between the financial services industry and faculty and students at the Georgia Institute of Technology, and Fiserv (Nasdaq: FISV), a leading global provider of payments and financial services technology with a flagship presence in Georgia, are partnering on a new initiative to better understand consumer financial health. Through this new initiative, Georgia Tech researchers will leverage Fiserv data to generate insights into household financial behavior, which will be relevant to policy makers, consumers and small businesses.

The three-year partnership, funded by Fiserv, has a goal of increasing financial and payments inclusion.

"With the annual inflation rate in the U.S. at a four-decade high, understanding the financial health of U.S. consumers and offering innovative ways to increase their financial resiliency is paramount," said Sudheer Chava, Alton M. Costley Chair Professor of Finance at the Georgia Tech Scheller College of Business, who leads the FSIL. "By combining insights from unique data with our team's expertise in household finance and big data analysis, we intend to deliver high-value insights about how major economic trends such as inflation affect U.S. consumers and small businesses."

As a company that enables money movement for thousands of financial institutions and millions of people and businesses, Fiserv will enable FSIL to construct a comprehensive picture of consumer spending and financial health. This will allow researchers to generate valuable insights about how consumers and small businesses are impacted by sudden economic changes as well as larger economic trends.

"At Fiserv, we believe data can be used for the greater good, to not only understand the financial health of consumers and small businesses, but to actively create opportunities to further financial inclusion," said Prasanna Dhore, Chief Data Officer at Fiserv. "By partnering with Georgia Tech, we will be able to grow our understanding of the populations and businesses who use our solutions every day, and take steps to positively impact people's financial lives."

About Fiserv

Fiserv, Inc. (NASDAQ: FISV) aspires to move money and information in a way that moves the world. As a global leader in payments and financial technology, the company helps clients achieve best-in-class results through a commitment to innovation and excellence in areas including account processing and digital banking solutions; card issuer processing and network services; payments; e-commerce; merchant acquiring and processing; and the Clover(R) cloud-based point-of-sale and business management platform. Fiserv is a member of the S&P 500(R) Index, the FORTUNE(R) 500, and has been recognized as one of FORTUNE World's Most Admired Companies(R) for 11 of the past 14 years and named among the World's Most Innovative Companies by Fast Company for two consecutive years. Visit fiserv.com and follow on social media for more information and the latest company news.

About the Financial Services Innovation Lab at the Georgia Tech Scheller College of Business

The FSIL was created to establish the Scheller College of Business and Georgia Tech as the hub for finance education, research, and industry. Responsible and sustainable finance is a major research focus for the FSIL, consistent with the broader Georgia Tech vision of inclusive innovation for a better future. The FSIL engages faculty, students, businesses, and practitioners through five interconnected channels: research, student learning experiences, events, recruiting, and facilitation of fintech entrepreneurship. Visit fintech.gatech.edu for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220722005102/en/

SOURCE: Fiserv, Inc.">

Media Relations: 
Chase Wallace
Director, Communications
Fiserv, Inc.
+1 470-481-2555
chase.wallace@fiserv.com

Additional Contact: 
Ann S. Cave
Vice President, External Communications
Fiserv, Inc.
+1 678-325-9435
ann.cave@fiserv.com
comtex tracking

COMTEX_410743502/1006/2022-07-22T09:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.